经皮冠状动脉介入治疗后的长期双联抗血小板治疗及同步优化药物治疗 - Suppr

Suppr

超能文献

Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.

作者信息

Gargiulo Giuseppe, Valgimigli Marco

机构信息

Department of Cardiology, Bern University Hospital, Bern, Switzerland.

Department of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy.

出版信息

Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S102-S106. doi: 10.21037/cdt.2017.03.10.

DOI:10.21037/cdt.2017.03.10

PMID:28748159

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5509929/

Abstract

摘要

相似文献

Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.

Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S102-S106. doi: 10.21037/cdt.2017.03.10.

A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.

Am Heart J. 2017 Mar;185:17-25. doi: 10.1016/j.ahj.2016.12.001. Epub 2016 Dec 9.

Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis.

J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):533-43. doi: 10.1177/1074248413495971. Epub 2013 Jul 19.

Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15.

Perioperative management of dual anti-platelet therapy.

Hosp Pract (1995). 2016 Dec;44(5):237-241. doi: 10.1080/21548331.2016.1260997. Epub 2016 Dec 4.

Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry.

Angiology. 2020 Mar;71(3):235-241. doi: 10.1177/0003319719895171. Epub 2019 Dec 23.

Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention.

Am J Med. 2017 Nov;130(11):1280-1289. doi: 10.1016/j.amjmed.2017.03.057. Epub 2017 Apr 29.

Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

Interv Cardiol Clin. 2017 Jan;6(1):25-37. doi: 10.1016/j.iccl.2016.08.003.

Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis.

Arch Cardiovasc Dis. 2015 Apr;108(4):235-43. doi: 10.1016/j.acvd.2014.11.004. Epub 2015 Feb 11.

Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia).

J Am Coll Cardiol. 2014 Feb 18;63(6):506-12. doi: 10.1016/j.jacc.2013.09.043. Epub 2013 Oct 23.

引用本文的文献

Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare.

Cardiovasc Diagn Ther. 2018 Oct;8(5):647-662. doi: 10.21037/cdt.2018.06.09.

本文引用的文献

Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial.

Catheter Cardiovasc Interv. 2017 Oct 1;90(4):E73-E84. doi: 10.1002/ccd.26921. Epub 2017 Feb 15.

Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.

EuroIntervention. 2017 May 15;13(1):78-86. doi: 10.4244/EIJ-D-16-00497.

A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?

Circulation. 2016 Dec 6;134(23):1881-1906. doi: 10.1161/CIRCULATIONAHA.116.023952.

Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials.

BMJ. 2016 Nov 3;355:i5483. doi: 10.1136/bmj.i5483.

Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents.

Circ Cardiovasc Interv. 2016 Nov;9(11). doi: 10.1161/CIRCINTERVENTIONS.116.004256.

Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.

J Am Coll Cardiol. 2016 Oct 25;68(17):1851-1864. doi: 10.1016/j.jacc.2016.07.760. Epub 2016 Aug 29.

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.

Circulation. 2016 Oct 4;134(14):989-998. doi: 10.1161/CIRCULATIONAHA.116.024531. Epub 2016 Aug 30.

Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.

JAMA Cardiol. 2016 Oct 1;1(7):795-803. doi: 10.1001/jamacardio.2016.2811.

Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial.

JACC Cardiovasc Interv. 2016 Sep 12;9(17):1780-9. doi: 10.1016/j.jcin.2016.05.046. Epub 2016 Aug 17.

Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.

Catheter Cardiovasc Interv. 2017 Feb 1;89(2):178-189. doi: 10.1002/ccd.26653. Epub 2016 Jul 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention.

作者信息

Gargiulo Giuseppe, Valgimigli Marco

机构信息

Department of Cardiology, Bern University Hospital, Bern, Switzerland.

Department of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy.

出版信息

Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S102-S106. doi: 10.21037/cdt.2017.03.10.

DOI:10.21037/cdt.2017.03.10

PMID:28748159

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5509929/

Abstract

摘要